Acusphere

Acusphere Gross Profit

The Gross Profit of Acusphere (ACUS) as of Nov 19, 2026 is -31.77 M USD.

Gross Profit

-31.77 MUSD

Last updated:

Gross Profit of Acusphere is 2008 -31.77 M USD. Gross Profit of Acusphere was 2007 - USD. It decreases by % lower compared to the previous year.

The Acusphere Gross Profit history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Profit
Date
Gross Profit
Jan 1, 2004
1.71 M USD
Jan 1, 2005
3.43 M USD
Jan 1, 2006
1.78 M USD
Jan 1, 2007
2.67 M USD
Jan 1, 2008
-31.77 M USD
The Acusphere Gross Profit history
YEARGross ProfitYoY
-31.77 MUSD-1,291.15%
2.67 MUSD+49.75%
1.78 MUSD-48.05%
3.43 MUSD+100.00%
1.71 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Acusphere Revenue

Acusphere Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2005
3.43 M USD
46.18 M USD
-44.63 M USD
Jan 1, 2006
1.78 M USD
62.28 M USD
-61.09 M USD
Jan 1, 2007
2.67 M USD
52.73 M USD
-53.73 M USD
Jan 1, 2008
2.68 M USD
-42.47 M USD
-67.73 M USD
Jan 1, 2009 (e)
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2010 (e)
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2011 (e)
656,132.00 USD
0.00 USD
0.00 USD
Jan 1, 2012 (e)
428,751.00 USD
0.00 USD
0.00 USD

Acusphere Margins

Acusphere stock margins

The Acusphere margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Acusphere. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Acusphere.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2005
100.00 %
1,346.82 %
-1,301.57 %
Jan 1, 2006
100.00 %
3,496.86 %
-3,430.04 %
Jan 1, 2007
100.00 %
1,977.02 %
-2,014.62 %
Jan 1, 2008
-1,183.61 %
-1,582.41 %
-2,523.62 %
Jan 1, 2009 (e)
-1,183.61 %
0.00 %
0.00 %
Jan 1, 2010 (e)
-1,183.61 %
0.00 %
0.00 %
Jan 1, 2011 (e)
-1,183.61 %
0.00 %
0.00 %
Jan 1, 2012 (e)
-1,183.61 %
0.00 %
0.00 %

Acusphere Stock analysis

What does Acusphere do? Acusphere Inc is a US-American company that was founded in 1993. It specializes in the development and marketing of advanced pharmaceuticals and therapeutic platforms in the fields of cardiology and pulmonology. The company is based in Lexington, Massachusetts and currently employs about 30 employees. The history of Acusphere goes back to the discovery of a new class of pharmaceutical agents, called microspheres. These spherical particles have a diameter of only a few micrometers and can have the ability to bind various therapeutic agents and release them in a targeted manner in the body. Acusphere has developed several innovative products and technologies based on these microspheres in recent years. One focus of the company is the development of therapies for patients with cardiovascular diseases such as heart failure or coronary artery disease. Another research area of ​​the company is the development of therapies for patients with lung diseases such as COPD or asthma. The business model of Acusphere is mainly based on the discovery and marketing of new drugs and therapies. In order to achieve these goals, the company works closely with leading scientific institutions and invests a significant portion of its budget in research and development. Acusphere is divided into several business areas, each of which includes different products and technologies. One of the most important business areas is the development of drugs for the treatment of cardiovascular diseases. An example of this is the drug EchoSphere, which was developed based on microspheres and is able to improve the oxygen supply to the heart muscle. Another important business area of ​​Acusphere is the development of products for the treatment of lung diseases such as COPD and asthma. For this purpose, the company has developed several new technologies that allow targeted delivery of medication to the lungs and its effects there. One of these technologies is the so-called Solutol technology, which allows medication to be concentrated in the alveoli of the lungs while avoiding unwanted side effects. In recent years, Acusphere has developed a number of innovative products and technologies that have great market potential due to their high efficacy and tolerability. The company is making every effort to bring these products to the market as quickly as possible and make a significant contribution to improving healthcare. Acusphere is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Acusphere stock

Gross Profit of Acusphere is -31.77 M USD in 2008.

On Eulerpool you can find the complete historical development of Gross Profit Acusphere since 2006 – with annual values, charts, and detailed analysis.

Gross Profit is the revenue remaining after deducting the cost of goods sold. It shows how efficiently a company uses its resources to produce goods or services.

Gross Profit's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Gross Profit's Acusphere historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Acusphere

All Key Metrics — Acusphere